Lotta von Boehmer

Medical Director, Early Clinical Development Hematology, Oncology, and Cellular Therapy

Lotta von Boehmer is a Medical Director at Bristol Myers Squibb, specializing in Early Clinical Development for Hematology, Oncology, and Cellular Therapy.2 3 Her role involves contributing to the development of innovative treatments in these critical areas of medicine.

Background and Education

Dr. von Boehmer has a strong academic foundation:

She holds a Ph.D., likely in a field related to her current work.
She completed her education at The Rockefeller University, a prestigious institution known for its contributions to biomedical research.2 4

Professional Experience

Prior to her current position at Bristol Myers Squibb, Dr. von Boehmer has had a diverse career:

She previously worked at the Institute for Immunity, Transplantation and Infection at Stanford University School of Medicine.1
She has also been affiliated with the Klinik für Onkologie at UniversitätsSpital Zürich in Switzerland.1

Research and Expertise

Dr. von Boehmer has made significant contributions to her field:

She has been cited 718 times in scientific literature, indicating her substantial impact on research.4
Her work has involved cancer immunotherapy, as evidenced by her participation in studies such as the phase I/IIa study of mRNA-based cancer immunotherapy for non-small cell lung cancer.1

Current Role

At Bristol Myers Squibb, Dr. von Boehmer is part of a team dedicated to advancing medical treatments:

She works in the Early Clinical Development division, focusing on hematology, oncology, and cellular therapy.2 3
This role likely involves overseeing clinical trials, analyzing data, and contributing to the development of new therapies in these fields.

Dr. von Boehmer's career trajectory showcases her expertise in immunology and oncology, making her a valuable asset in the development of cutting-edge treatments at Bristol Myers Squibb.